Literature DB >> 16815134

The genetics of atopic dermatitis.

Nilesh Morar1, Saffron A G Willis-Owen, Miriam F Moffatt, William O C M Cookson.   

Abstract

Atopic dermatitis (AD) is a chronic itching (pruritic) skin disease. It results from a complex interplay between strong genetic and environmental factors. Genome screens of families with AD have implicated chromosomal regions that overlap with other skin diseases and with inflammatory and autoimmune diseases. These, together with candidate gene studies, provide novel insights into the pathogenesis of AD. The findings suggest a common theme of generalized epidermal dysfunction manifesting as a compromised skin barrier and failure to protect against, or aberrant responses to, microbial insults and antigens. Recent genetic advances with high-throughput methods for gene identification, such as DNA microarrays and whole-genome genotyping, will help further dissect this complex trait. This will aid disease-defining criteria and focused therapies for AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815134     DOI: 10.1016/j.jaci.2006.03.037

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  42 in total

Review 1.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

Authors:  Jonathan J Lyons; Joshua D Milner; Kelly D Stone
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

2.  Ets1 suppresses atopic dermatitis by suppressing pathogenic T cell responses.

Authors:  Choong-Gu Lee; Ho-Keun Kwon; Hyeji Kang; Young Kim; Jong Hee Nam; Young Ho Won; Sunhee Park; Taemook Kim; Keunsoo Kang; Dipayan Rudra; Chang-Duk Jun; Zee Yong Park; Sin-Hyeog Im
Journal:  JCI Insight       Date:  2019-03-07

Review 3.  Atopic Dermatitis and Allergic Urticaria: Cutaneous Manifestations of Immunodeficiency.

Authors:  Martin Robert Gaudinski; Joshua D Milner
Journal:  Immunol Allergy Clin North Am       Date:  2016-10-28       Impact factor: 3.479

4.  Lower prevalence of common filaggrin mutations in a community sample of atopic eczema: is disease severity important?

Authors:  Robert Gruber; Andreas R Janecke; Daniela Grabher; Elisabeth Horak; Matthias Schmuth; Peter Lercher
Journal:  Wien Klin Wochenschr       Date:  2010-09-27       Impact factor: 1.704

5.  The melanocortin 1 receptor (MC1R) inhibits the inflammatory response in Raw 264.7 cells and atopic dermatitis (AD) mouse model.

Authors:  Wei Chen; Jianping Li; Hai'e Qu; Zhou Song; Zhanqing Yang; Jinlong Huo; Huaizhi Jiang; Qinghua Huang; Meixia Huo; Bo Liu; Qiaoling Zhang
Journal:  Mol Biol Rep       Date:  2012-10-23       Impact factor: 2.316

6.  Genome-wide association analysis of canine atopic dermatitis and identification of disease related SNPs.

Authors:  Shona Hiedi Wood; Xiayi Ke; Tim Nuttall; Neil McEwan; William E Ollier; Stuart D Carter
Journal:  Immunogenetics       Date:  2010-01-05       Impact factor: 2.846

7.  Involvement of Fc(epsilon)R1beta gene polymorphisms in susceptibility to atopy in Korean children with asthma.

Authors:  Eun Soo Kim; Seung-Hyun Kim; Kyung Won Kim; Hae-Sim Park; Eun Soon Shin; Jong Eun Lee; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Eur J Pediatr       Date:  2009-03-14       Impact factor: 3.183

Review 8.  Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Authors:  Robert C Kern; David B Conley; William Walsh; Rakesh Chandra; Atsushi Kato; Anju Tripathi-Peters; Leslie C Grammer; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008-09-10

9.  Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma.

Authors:  Shadmehr Demehri; Mitsuru Morimoto; Michael J Holtzman; Raphael Kopan
Journal:  PLoS Biol       Date:  2009-05-19       Impact factor: 8.029

10.  Detection of R576 interleukin-4 receptor an allele gene, serum interleukin-4, and eosinophilic cationic protein in atopic dermatitis patients.

Authors:  M Y Abdel-Mawla; Y Mostafa; Y Abuel-Majd; Rasha Attwa
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.